These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 32178700)

  • 1. In vitro modeling of the neurovascular unit: advances in the field.
    Bhalerao A; Sivandzade F; Archie SR; Chowdhury EA; Noorani B; Cucullo L
    Fluids Barriers CNS; 2020 Mar; 17(1):22. PubMed ID: 32178700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies.
    Sivandzade F; Cucullo L
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1667-1681. PubMed ID: 30058456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic models of the neurovascular unit: a translational view.
    Wevers NR; De Vries HE
    Fluids Barriers CNS; 2023 Nov; 20(1):86. PubMed ID: 38008744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects.
    Kawakita S; Mandal K; Mou L; Mecwan MM; Zhu Y; Li S; Sharma S; Hernandez AL; Nguyen HT; Maity S; de Barros NR; Nakayama A; Bandaru P; Ahadian S; Kim HJ; Herculano RD; Holler E; Jucaud V; Dokmeci MR; Khademhosseini A
    Small; 2022 Sep; 18(39):e2201401. PubMed ID: 35978444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.
    Palmiotti CA; Prasad S; Naik P; Abul KM; Sajja RK; Achyuta AH; Cucullo L
    Pharm Res; 2014 Dec; 31(12):3229-50. PubMed ID: 25098812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro blood brain barrier models: An overview.
    Jagtiani E; Yeolekar M; Naik S; Patravale V
    J Control Release; 2022 Mar; 343():13-30. PubMed ID: 35026351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies.
    Teixeira MI; Amaral MH; Costa PC; Lopes CM; Lamprou DA
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview.
    Archie SR; Al Shoyaib A; Cucullo L
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances towards overcoming the blood-brain barrier.
    Ali A; Sohail Arshad M; Ahmad Khan M; Chang MW; Ahmad Z
    Drug Discov Today; 2023 Oct; 28(10):103735. PubMed ID: 37573965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Neurovascular Unit and Blood-Brain Barrier for Ischemic Stroke Modeling.
    Liu Z; Tang Y; Zhang Z; Liu Q; Wang M; Li W; Yang GY
    Adv Healthc Mater; 2023 Jul; 12(19):e2202638. PubMed ID: 37075477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier on a chip.
    Chin E; Goh E
    Methods Cell Biol; 2018; 146():159-182. PubMed ID: 30037460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases.
    Chen X; Liu C; Muok L; Zeng C; Li Y
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication.
    Erickson MA; Wilson ML; Banks WA
    Fluids Barriers CNS; 2020 Mar; 17(1):26. PubMed ID: 32228633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of the Neurovascular Unit by Psychostimulant Drugs.
    Vo TTL; Shin D; Ha E; Seo JH
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines.
    Pérez-López A; Torres-Suárez AI; Martín-Sabroso C; Aparicio-Blanco J
    Adv Drug Deliv Rev; 2023 May; 196():114816. PubMed ID: 37003488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, Emerging Chip Models of the Blood-Brain Barrier and Future Directions.
    Holloway PM
    Methods Mol Biol; 2022; 2492():193-224. PubMed ID: 35733046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface.
    Phan DT; Bender RHF; Andrejecsk JW; Sobrino A; Hachey SJ; George SC; Hughes CC
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1669-1678. PubMed ID: 28195514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating in vitro disease models of the neurovascular unit into discovery and development of neurotherapeutics.
    Ding Y; Shusta EV; Palecek SP
    Curr Opin Biomed Eng; 2021 Dec; 20():. PubMed ID: 34693102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.